For detection of respiratory syncytial virus (RSV), the BD Directigen RSV rapid antigen assay was compared to Cepheid's real-time reverse transcriptase PCR RSV analyte-specific reagents. The Directigen RSV assay resulted in a 23% false-negative rate, using PCR and chart review as the gold standard, indicating that rapid RSV PCR results would be advantageous.Rapid detection of respiratory viruses is important for many reasons, including prevention of unnecessary antibiotic use, identification of individuals who can benefit from antivirals, and improvement of infection control by grouping individuals with the same viral infection. Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in young children (17). Three percent of all children are hospitalized with bronchiolitis in the first year of life, and RSV is the most common cause of this hospitalization (2). An estimated 50% of all children are infected with RSV during the first year of life, and by 3 years of age, 100% have experienced at least one infection (14). Since RSV infection does not induce protective immunity, reinfection is common.Diagnosis of RSV infection can be made by observation of clinical signs and symptoms, characteristic chest radiographs, rapid antigen detection, viral culture, or reverse transcriptase PCR (RT-PCR) of nasopharyngeal (NP) specimens (2). The most common laboratory method for rapid detection of RSV includes rapid antigen (enzyme immunoassay) assays produced by multiple manufacturers, with various sensitivities of 57 to 98% and specificities between 70 and 100% (1,5,10,11,13,16,20). Other diagnostic tests include culture (routine tissue culture and shell vial culture), with sensitivities between 70 and 80% and specificities of 100% (10,11,19), and direct fluorescent antigen detection, with sensitivities between 93 and 100% and specificities of 95 to 100% (1, 10, 16). More recently, real-time RT-PCR assays have been described as demonstrating sensitivities of 73 to 97% and specificities of 64 to 99% (7,9,11). In this study, we compared assays using Cepheid's RSV analyte-specific reagents (ASR) to the BD Directigen RSV rapid antigen assay (BD Diagnostics, Sparks, MD).Respiratory specimens (n ϭ 142) consisting of NP aspirates (n ϭ 140) and NP swabs (n ϭ 2) from the 2005-2006 peak season were initially tested for RSV by the rapid antigen assay, following the manufacturer's protocol. The samples were put into 2 ml of viral transport media prior to being tested; for NP aspirates, the entire volume received was inoculated. These specimens were from patients ranging from 3 days to 74 years of age. Sixty-eight percent (n ϭ 96) of the specimens were from infants (less than 1 year of age), 21% (n ϭ 30) from individuals between 1 and 5 years of age, and 11% (n ϭ 16) from individuals who were greater than 5 years of age. By the rapid antigen assay, 34% (n ϭ 48) of the specimens were RSV positive. Of the positives, 81% (n ϭ 39) were from individuals less than 1 year of age, 13% (n ϭ 6) from individuals 1 to 5 years of ag...